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Although itisknown that Tcell help is required forthe induction ofIgE synthesis
(1), the precise requirements for IgE synthesis have not been fully delineated. It is
known thatIL-4 is importantfor IgE synthesis, since murine B cellsstimulated with
LPSwill synthesizeIgE andIgG1 in the presenceofIL-4 (2-7). In addition, murine
Th2 clones, whichproduce IL-4 and IL-5, but not Thl clones, whichproduce IL-2
and IFN--y, have been shown to induce IgE synthesis when cultured directly with
B cells (8). Furthermore, in vivo administration of anti-IL-4 mAb inhibits murine
polyclonal IgE responses, confirming the requirement ofIL-4 for IgE synthesis (9,
10). Although other lymphokines that may be involved in IgE synthesis have been
purified and cloned, the exact roles ofthese molecules have been difficult to define
in part because many can stimulate both B cells and T cells, often delivering mul-
tiple signals to the same lymphocyte (11).
Since LPS does not elicit potent activation signals in human B cells, much ofour
understanding ofthe requirements for human IgE synthesis has been generated by
examination of IgE synthesis induced by culturing B cell-enriched populations in
the presence ofIL-4 (12-15). Although IL-4 appears necessary for human IgE syn-
thesis (16), the role ofotherB cell growth or differentiation factors, or the exact role
of subsets of human CD4+ Tcells in the induction ofIgE synthesis, has not been
fully determined.
The purpose ofour current studies was to examine the precise requirements for
the induction ofhuman IgE synthesis using a panel ofCD4+ T cell clones and sev-
eral different experimental approaches. First, we compared the capacity of several
well-characterized alloantigen-specific CD4+ T cell clones, which expressed different
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profiles of lymphokine secretion, to induce IgE synthesis in purified B cells under
cognate conditions in which the B cells expressed alloantigens recognized by the
cloned T cells. Undersuch conditions, which mimic MHC-restricted B-T cell inter-
actions (17-19), we demonstrated that not all T cell clones that produce IL-4 are
capable of inducing IgE synthesis, indicating that factors in addition to IL-4 are
required. We further determined that low molecularweight B cell growth factor(LMW
BCGF)t played a significant role in IgE synthesis, since it restored the capacity of
some "IgE-nonhelper" T cell clones to induce IgE synthesis. In addition, we exam-
ined IgE synthesis induced by cloned T cellspretreated with cyclosporin A to inhibit
lymphokine secretion. Using cyclosporin A-pretreated T cell clones, we determined
that restoration ofthe capacity of such T cells to induce IgE synthesis required the
addition of both IL-4 and LMW-BCGF. IL-2, but only when added with IL-4 and
LMWBCGF, also had an enhancing effect on IgE synthesis in this system. Collec-
tively with these different experimental approaches, we have demonstrated that IL-4,
although required for human IgE synthesis, is by itself not sufficient. Optimal in-
duction of IgE synthesis required exposure ofB cellsto a particular complex of signals,
which included signals provided by the cognate interaction between B cell and T cell,
by IL-4, LMW-BCGF, and by IL-2, all of which synergized to stimulate the syn-
thesis of large quantities of IgE.
Materials and Methods
Monoclonal Antibodies.
￿
Anti-Leu-1 mAb was purchased from Becton Dickinson & Co.
(Mountain View, CA). mAbs against human IgE (numbers 8 and 9) were obtained from
Dr. Ruben Siraganian (National Institute of Dental Health, Bethesda, MD). Rat anti-human
IL4 mAb, 25D2, was prepared by immunizing a Lewis rat with purified Cos7-expressed hu-
man IL-4, and was capable of neutralizing the T cell growth factor bioactivity of rIL-4 on
PBMC (20).
Lymphokines.
￿
Human rIL-2 and IFN-.y were obtained from Amgen Corp., Thousand Oaks,
CA. Human rIL-4 was purchased from Genzyme, Boston, MA and from Amgen Corp. Human
rIL-5 (Cos supernatants) were generously provided by Dr. Steven Clark, Genetics Institute
(Boston, MA) and by Dr. Frank Lee, DNAXResearch Institute. Purified LMW-BCGF was
purchased from Cellular Products, Buffalo, NY Human rTNRa and human recombinant
lymphotoxin (TNR0) were obtained from Genentech, Inc., S. San Francisco, CA.
Preparation ofPeripheralBloodB Cells.
￿
PBMC were isolated from the blood of normal adult
donors by flotation over Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ). PBMC
were then washed three times with PBS, and rosetted with aminoethylisothiouronium-treated
sheep cells. The erythrocyte rosette-negative cells were enriched by flotation over Ficoll-
Hypaque, and were further purified by treatment with Leu-1 mAb and baby rabbit comple-
ment to remove residual T cells (21). The resulting B cell population contained 40-50% mono-
cytes but <1% T cells.
Percoll Gradients.
￿
5-10 x 106 E-rosette (-) cells were placed on discontinous Percoll gra-
dients as described (21), and centrifuged at 1,280g for 15 min at 4°C. Low density and high
density B cells were recovered in the fractions between 40/50% and 60/70%, respectively.
Preparation of T Cell Clones.
￿
Alloantigen-specific CD4' T lymphocytes clones were gener-
ated by limiting dilution as previously described (22, 23). Briefly, PBMC were stimulated
with irradiated allogeneic PBMC for 6 d. Dividing cellswere enriched by centrifugation over
discontinous gradients ofPercoll (Pharmacia Fine Chemicals) at 1,500 rpm for 45 min. Cells
at the 30-50%v interface were cultured in DME at limiting dilution (0.3 cell/well)with irradi-
' Abbreviations used in thispaper . LMW-BCGF, lowmolecular weight B cell growth factor; SAC, Staph-
ylococcus A, Cowan strain.DEKRUYFF ET AL.
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ated PBMC added every 7 d. These CD3', CD4', CD8- clones have been subcloned and
maintained in long-term culture in DME containing 10% FCS (Sterile Systems, Inc., Logan,
UT) by repeated stimulation with irradiated allogeneic PBMC and IL-2-containing super-
natants.
IL-2 Assay.
￿
Human IL-2 activity was determined by using the murine IL-2-responsive
T cell line HT2 (generously provided by Dr Sam Strober, Stanford University). HT2 cells
were added to triplicate wells (5,000 cells/well) ofa 96-well platewith or without IL-2-containing
supernatants or human rIL-2. mAbs to the mouse IL-2 receptor (7134 + 3C7 + PC61.53),
were added to some wells to specifically inhibit IL-2-induced proliferation. Proliferation of
these cellswas assessed by the incorporation of [3H1thymidine over the last 7 h of a 24-h cul-
ture period. Specificity of the IL-2 assay was assured by the fact that human IL-4 is species
specific and does not bind to mouse T cells, by the failure of anti-mouse IL-2 receptor mAb
to inhibit proliferation induced with mouse IL-4, and by the failure ofmAb 11B11 (anti-mouse
IL-4) to inhibit proliferation induced by rIL-2 (24, 25).
Solid-Phase Immunoassayfor IL-4.
￿
IL-4 activity in T cell clone supernatants was assayed
in an ELISA assay, using rabbit anti-human IL-4 IgG and a rat monoclonal anti IL-4 anti-
body (20). In this assay for human IL-4, no signal was generated by IL-1, IL-2, IL-3, IL-5,
IFN-y or IFN-a, granulocyte/macrophage CSF, granulocyte CSF, B cell stimulatory factor
2/IL-6, or TNFa and TNF0.
TNF-cr and IFN-y.
￿
TNFce and IFN-y levels were determinedby ELISAs specific for each
cytokine. The assay for human TNFa detects 50 pg/ml (2.5 U/ml), and the assay for human
IFN-1' detects 4 pg/ml (4 U/ml). In these assays, human rTNFce has a specific activity of
5 x 101 U/mg, and rIFN-y has a specific activity of 1 x 10' U/mg (26).
TNF-,B.
￿
TNF-0 was assayed using an L-M bioassay with a detection limit of 20 pg/ml
(4 U/ml) (27). To determine the concentration ofTNF-(3, all TNFa activity was first neutral-
ized by adding a fivefold excess of a rabbit polyclonal anti-human rTNFci antibody, for at
least 30 min before assay at 37°C. This antiserum has a neutralizing titer of N3 x 104 L-M
units and shows no neutralizing activity against TNFS. In the L-M bioassay, human rTNFa
has a specific activity of 5 x 107 U/mg of protein, and recombinant human TNF-0 has a
specific activity of 2 x 108 U/mg of protein (27).
Supernatants.
￿
Supernatants were generated from T cell clones (106 cells/ml) by stimula-
tion with alloantigen on appropriate stimulator cells (106 monocytes/ml) for 24 h. For TNFa,
IFN-y, and lymphotoxin determinations, supernatants were generated by stimulation with
PHA-P (Difco Laboratories, Detroit, MI) for 24 h.
Induction of Ig Synthesis.
￿
Cultures were performed in 96-well microtiter plates in DME
containing 10% FCS. E-rosette-negative cells (1 x 105 per well) were cultured with 4 x 104
cloned T cells and 2 x 104 irradiated (2,500 rad) monocytes in 200 A1 of complete media.
Supernatants from triplicate wells were combined after 9 d of culture and assayed in dupli-
cate. ELISAs of supernatants for IgG and IgM were performed as described (22). ELISA
for IgE was performed in 96-well polystyrene plates coated with two anti-human IgE mAbs
(1 ug/ml). After washing with PBS with 0.1% Tween 20, the plates were blocked with a 0.1
BSA solution for 1 h and washed, and 0.1 ml ofappropriately diluted supernatants was added
to the wells. Afer 18 h, the plates were again washed, and biotinylated goat anti-IgE (Tago
Inc., Burlingame, CA) was added for 60 min. The plates were washed and horse radish per-
oxidase-labeled streptavidin (Zymed Laboratories, San Francisco, CA) was added for60 min.
Bound enzyme was quantitated using the substrate o-phenylene diamine (Sigma Chemical
Co., St. Louis, MO) for 30 min, and the absorbanceat 414 nm was read on a Bio-Rad Labora-
tories (Richmond, CA) automatic ELISA reader. Standard curves for IgE were performed
usingpurified IgE (Pharmacia Fine Chemicals). The lowerlimit of this assay is 0.15 ng/ml.
Specificity has been demonstrated by adding human IgG or IgM antibody (up to 500 ug/ml)
as sample, resulting in an absorbance no higher than an absorbanceequivalent to <0.15 ng/ml.
Cyclosporin A Pretreatment of T Cell Clones.
￿
Stock solutions of cyclosporin A (generously
provided by Dr. David Winter, Sandoz Research Institute, E. Hanover, NJ) were prepared
by dissolving 1 mg in 0.1 ml ethanol, adding 0.02 ml Tween 80, and mixing. RPMI 1630
was added dropwise to a final volume of 1.0 ml. T cell clones were incubated overnight at
1 x 106 cells/ml in 3-6 hg/ml of cyclosporin A at 37°C for 24 hr. Viable cells were recov-
ered, washed, and cultured with purified B cells, as described by Krusemeir and Snow (28).1480 INTERLEUKIN 4 AND B CELL GROWTH FACTOR IN IgE SYNTHESIS
Results
Study of human IgE synthesis has been hampered not only by the inability of
polyclonal B cell activators to induce IgE synthesis but also by the complexity of
the different cytokine profiles expressed by cloned human CD4+ T cells, compared
with that in themouse. We initiatedour studyofinduction ofIgEsynthesisby gener-
ating alloantigen-specific CD4+ helper T cell clones that were heterogeneous with
regard to their lymphokine profiles. Table I lists the alloantigen-specific CD4+ T
cell clones that were used in ourstudies. CloneH8 secretes IL-2 but notIL-4. Clone
D12 secretes IL-4, but not IL-2 or IFN-y. Clone H9 secretes IL-2, IL-4, andIFN-y,
whileclone D11 secretes TNFa and lymphotoxin, but neither IL-2 norIL-4. These
alloantigen-specific clones have been maintained in long-term culture by repeated
stimulation with irradiated feeder cells and have retained theirlymphokine profiles
for>6 mo. We used this panel of T cell clones to determine the lymphokine require-
ments for the induction of IgE synthesis.
CD4+ T Cell Clones with D ecent Lymphokine ProfilesHave Di ,ffering Capacities to Induce
IgESynthesis.
￿
Ourfirst approach in studying the requirements forhuman IgE syn-
thesis was to examine the induction of IgE synthesis using the CD4+ clones with
different lymphokine profiles, and to correlate the capacity to induce IgE with the
secretion of various lymphokines. Each T cell clone was cultured with purified B
cells expressing the alloantigen recognized by the particular T cell clone. Such con-
ditions mimic normal T cell-B cell MHC-restricted interactions where the B and
T cells are bridged via alloantigen, and have been shown to be very effective at in-
ducing IgE synthesis (22, 29, 30). Table II shows the results using a noncytolytic
alloantigen-specific CD4+ clone, H9, which secretes both IL-2 and IL-4. Clone H9
was capable of inducing large quantities of all isotypes, including IgG, IgM, IgA,
and IgE. Addition of IL-2, or IL-4, or IFN-yhad little effect on Ig synthesis. These
results indicate that the clone H9 produced factors important for the synthesis of
all Ig isotypes, including IgE, and that providing excess quantities of IL-2, IL-4,
or IFN-y was of little value.
OptimalInduction ofIgE Synthesis by SmallDense B CellsRequires the Presence ofCloned
TCells. In the previous experiments, the B cells expressed alloantigens recognized
by cloneH9 andtherefore couldbe directly stimulated by theT cell clone. However,
TABLE I
The CD4+ T Cell Clones Used in These Studies
Supernatants tested for IL-2 and IL-4 activity were generated by stimulating
the T cell clones with purified irradiated monocytes expressing the appropriate
stimulatory alloantigens, while supernatants tested for IFN-y, TNF-a, and lym-
photoxin were generated by stimulation with PHA-P (Difco Laboratories), 1:200.
Each cytokine assay is described in Materials and Methods.
Clone IL-2
cpm
IL-4
pg/ml
IFNJy
p9/ml
TNF-a
pg/ml
Lymphotoxin
pg/ml
H8 93,580 181 2,000 637 1,740
D12 756 8,145 <400 <30 205
H9 98,905 5,327 2,600 355 90
D11 121 282 4,800 908 2,355
Control 98 <100 <400 <50 <20DEKRUYFF ET AL.
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TABLE II
Induction ofIg Synthesis by a T Cell Clone Secreting Both IL-2 and IL-4
Purified B cells (105 cells/well) were cultured for 9 d with and without cloned
T cells (4 x 104 cells/well) under cognate T-B cell conditions and the indicated
lymphokine. Supernatants were harvested and tested by ELISA for Ig content.
IL-2 was used at 2 U/ml, IL-4 at 1,000 U/ml, and IFN-.y at 20 U/ml. In other
experiments, addition of larger amounts ofIL-2 (up to 20 U/ml), or ofIL-4 (up
to 2,000 U/ml) gave similar results. Addition of larger amounts of IFN--y (250-
2,500 U/ml) resulted in a 50% decrease in IgE synthesis.
since small quantities ofIgE were secreted in the absence ofcloned T cells (Table
II, lines 5, 6, and 7), it was important to determine the precise role of the T cell
clone, and whether some or all ofthe B cells could respond to soluble lymphokines
in theabsenceofTcells. E-rosette-negative cells were therefore separated on Percoll
density gradients into large (low density) and small (high density, resting) B cells.
Table III shows that low density B cells secreted IgE spontaneously, and secretion
doubled in response to soluble IL-2 plus IL-4 in the absence ofT cells. In contrast,
small dense Bcells didnot secrete IgE spontaneously, and addition ofIL-2 andIL-4
(Table III, line 4) or of supernatants from clone H9 (data not shown) to purified
smalldenseB cellshad no effect on IgE synthesis inthe absenceofTcells. Moreover,
addition ofclone H9 to the small B cells resulted in the synthesis ofIgG, IgM, and
IgE. These results indicated that large B cells secrete IgE spontaneously and can
respond to soluble lymphokines. On the other hand, small resting B cells do not
TABLE III
Small Resting B Cells Require the Presence of T Cells
for the Generation ofIg Responses
Purified B cells were separated on Percoll density Gradients into small dense and
large partially activated B cells. Such B cells (10 cells/well) were cultured for
9 d with and without done H9 (secreting IL-2, IL-4, and IFN-'(; 4 x 104 cells/
well) under cognate conditions and with the indicated lymphokines. IL-2 was
used at 4 U/ml and IL-4 was used at 1,000 U/ml.
Stimulus IgG IgM
ng/ml
IgA IgE
H9 39,232 130,735 42,284 77.28
H9 + IL-2 28,653 71,705 28,659 81.88
H9 + IL-4 35,903 78,955 33,425 109.56
H9 + IFN-.y 30,438 110,445 42,889 92.72
None 94 <58 238 1.95
IL-2 133 <58 351 2.76
IL-4 158 <58 364 3.41
B cells Clone H9 IgG IgM
ng/ml
IgE
Large (low density) - 381 194 9.69
Large + IL2 + IL4 - 773 172 17.97
Small (high density) - <58 191 <0.31
Small + 112 + IL4 - 105 345 <0.31
Small + 103,165 125,275 41 .121482 INTERLEUKIN 4 AND B CELL GROWTH FACTOR IN IgE SYNTHESIS
respond to soluble lymphokines, but require the presence ofT cells to stimulate de
novo IgE synthesis . In subsequent experiments, therefore, since we wished to study
the effect of clonedT cells on the induction of Ig synthesis, we used purified B cell
populations that did not respond to soluble lymphokines in the absence ofT cells .
Induction of IgE Synthesis in the Presence ofmAb against IL-4 .
￿
Since IL-4 has been
shown to be necessary for the induction of IgE (2-9, 12-16), we attempted to selec-
tively inhibit induction of IgE synthesis by clone H9 with the addition of a neu-
tralizingmAb against IL-4 . In all experiments (n = 5), using cloneH9 andB cells
under cognate conditions, the anti-IL-4 mAb failed to inhibit IgE synthesis (data
not shown) . This is consistent with experiments with murine T cell clones, inwhich
the presence ofmAb to IL-4 had little effect on Ig synthesis (31) . This was thought
to bedue to theclosephysical interaction betweenTandB cells (32), such that IL-4
is transferred between the cells in a manner that is refractory to antibody blockade .
In contrast to these experiments with B cells stimulated under cognate conditions,
Fig . 1 shows that using clone H9 under noncognate conditions with largeB cells
from an allergic donor, the anti-IL-4mAb was very effective in inhibiting IgE syn-
thesis . These results confirmed that IL-4 is required for the induction of IgE syn-
thesis, in partially activated B cells under noncognate conditions .
Induction ofIgE Synthesis Requires the Presence ofIL-4.
￿
We next examined the ability
ofa clone that did not produce detectable levels of IL-2 or IL-4 to induce IgE syn-
thesis, to determine ifIgE synthesis could occur in the absence of IL-4 . Table IV
shows that culture of clone D11 with purified B cells resulted in synthesis ofsome
IgG, IgM, and IgA, and these levels dramatically increased with the addition of
IL-2 . In contrast, IgE synthesis was negligible even in the presence of IL-2, but in-
creased substantially with the addition of IL-4 . Spontaneous IgE synthesis by the
B cells was minimal, and almost no IgE synthesis occurred with IL-4 in the absence
of cloned T cells . Therefore, few partially activated B cells were present in these
cultures, and the presence ofT cells was required for IgE synthesis . Since addition
FIGURE 1 .
￿
IgE antibody synthesis is inhibited
by anti-IL-4mAbunder noncognate B-T cell con-
ditions . Anti-IL-4 mAb was added at the indi-
cated dilution to cultures ofB cellsandcloneH9
(secreting IL-2, IL-4, and IFN-.y) . The appro-
priate irradiated monocytes were added to acti-
vate clone H9, since the B cells did not express
alloantigens recognized by the done .DEKRUYFF ET AL.
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TABLE IV
Ig Synthesis Induced by a T Cell Clone that Does Not Secrete IL-4
is Selectively Enhanced by IL-2 or IL-4
Purified B cells were cultured as described in Table I, with clone Dl l, which
does not secrete detectable levels of IL-2 or IL-4. IL-2 was added at 2 U/ml,
and IL-4 was added at 1,000 U/ml. Similar results were obtained in two other
experiments.
of IL-2 with clone D11 to B cells selectively increased IgG but not IgE synthesis,
it wasunlikely that IL-2affectedIgsynthesisindirectly byenhancingTcell survival.
Similarly, since addition ofIL-4 with clone D11 selectively enhanced IgE synthesis,
it was unlikely that IL-4 affected Ig synthesis by enhancingTcell survival. Rather
these results suggest that IL-2 and IL-4 have differential but direct effects on the
Bcell, that IL-2 isapotent B celldifferentiationfactor (especially for IgG synthesis),
and support the idea that while IgG synthesis does not require IL-4, IgE synthesis
is absolutely dependent on the presence of IL-4.
An IL-2-producing TCell Clone that Suppresses IgE Synthesis.
￿
We next examined the
capacity of another clone, H8, which produced IL-2 but not IL-4, to induce IgE
synthesis. Like mouse Thl clones, this clone was unable to induce IgE synthesis
whenculturedwith B cells expressing the appropriate alloantigen (Fig. 2). Addition
of IL-2 or of IL-4 did not enhance the synthesis of IgE (data not shown). In fact,
in cocultureexperiments, clone H8 inhibited synthesis ofIgG, IgM, IgA, and IgE
induced by clone H9 (Fig. 2). Thus this T cell clonehad an inhibitory role on IgE
synthesis, similarto that whichhas been reported in the past forIgG synthesis with
both human and murine T cell clones (23, 33).
IL-4 Is RequiredfortheInduction ofIgESynthesis ButIs NotSufficient Alone.
￿
Because
IL-4 appeared necessary forthe inductionofIgE, we expectedthat clone D12,which
produces IL-4 but not IL-2, would be very effective ininducing IgE synthesis when
cultured with B cells. However, clone D12 induced only modest amounts ofIgG or
IgEwhen cultured with B cellsexpressing the target alloantigen (Table V). Addition
of IL-2 to these cultures reversed the failure of clone D12 to induce IgG, but had
only a marginal effect on IgE synthesis. In contrast, addition of IL-4 to these cul-
tures did not affect IgE or IgG synthesis. These results again indicated that while
IgE synthesis required the presence of IL-4, other factors that were not provided
by clone D12 were also necessary for IgE synthesis to occur.
CommercialLMW-BCGFPlaysan ImportantRolein IgESynthesis.
￿
Wenextattempted
to determine what additional factors were needed by clone D12 to induce IgE syn-
thesis. Since commercially available LMWBCFGhasbeen previously showntobe
a potent B cell stimulus (34-36), we asked ifLMWBCGF would have an effect on
Stimulus IgG IgM
ng/ml
IgA IgE
D11 34,332 3,233 9,511 1 .94
D11 + IL-2 188,620 40,746 58,846 1 .96
Dll + IL-4 21,792 10,576 11,877 25.06
None <39 <58 <270 1 .30
IL-2 44 <58 214 <0.31
IL-4 <39 <58 239 0.441484 INTERLEUKIN 4 AND B CELL GROWTH FACTOR IN IgE SYNTHESIS
FIGURE 2 . IL-4 and LMW-
BCGF reconstitute the capacity
ofclone D12 (secreting IL-4 but
not IL-2 or IFN-y) to induce
IgE synthesis . Clone D12 was
cultured with purified B cells
andthe indicated lymphokines :
IL-2 at 2, 4, or 10 U/ml, IL-4
at 500U/ml, andLMWBCGF
at a 1 :20 dilution . IgE in cul-
ture supernatants was deter-
mined after 9 d of culture .
IgE synthesis in our cultures . Fig . 3 shows that addition of both LMW-BCGF and
large amounts ofIL-4 dramatically increased IgE synthesis . Furthermore, IgE syn-
thesis was optimal with the addition of IL-2, IL-4, andLMWBCGF. This combi-
nation of lymphokines appeared to act directly on the B cell and not by improving
the survival of the cloned T cells, since IL-2 by itself had a relatively small effect
on the induction ofIgE synthesis. However, the possibility that these lymphokines
together were enabling cloneD12 tomore effectively secrete otherlymphokines could
not be excluded .
Induction ofIgE Synthesis with Cyclosporin A-pretreated T Cell Clones.
￿
To more pre-
cisely evaluate the requirements for IgE synthesis, we adopted a system developed
TABLE V
Ig Synthesis Induced by an IL-4-secreting T Cell Clone Is Enhanced with IL-2
Purified B cells were cultured as described in Table IV with clone D12, which
secretes IL-4 but not IL-2 . IL-2 was added at 10 U/ml, and IL-4 was added
at 1,000 U/ml . Similar results were obtained in three other experiments .
Stimulus IgG Igm
ng/ml
IgA IgE
D12 485 678 649 3.98
D12 + IL-2 10,112 13,615 12,803 6.03
D12 + IL-4 614 673 844 4.12
None 49 <58 171 <0.31
IL-2 32 <58 96 <0.31
IL-4 110 105 267 <0.31by Krusemeier and Snow (28) usingCD4+T cell clones pretreated with cyclosporin
A to prevent the release of soluble lymphokines . Table VI shows that treatment of
clone H9 with cyclosporin A abolished its capacity to induce IgG, IgM, and IgE
in purified B cells. Although cyclosporin A-treated T cells were unable by them-
selves to induce Ig synthesis (line 2), the interaction of the treated T cells with B
cells allowed the B cells to develop the capacity to respond to exogenously added
soluble lymphokines . Thus the addition of IL-2, IL-4, andLMWBCGF to these
cultures resulted in the synthesis of IgG, IgM, and >450 ng/ml of IgE . Although
cyclosporin A pretreatment may not have completely abolishedT cell secretion of
alllymphokines, and although cyclosporinA did not affect secretion of factors from
monocytes, cyclosporin pretreatment was useful in separating the signals provided
by the direct interaction of theT cell with theB cell from signalsprovided by soluble
lymphokines .
IL-4plusLMW-BCGFwith Cyclosporin A-treatedTCells Selectively Enhances IgE Synthesis.
We next attempted to find a combination ofadded lymphokines that would selec-
TABLE VI
Induction of IgE Synthesis with Clone H9 Pretreated with Cyclosporin A
DEKRUYFF ET AL .
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FIGURE 3 .
￿
Clone H8 (secret-
ing IL-2 and IFN--f) does not
induce IgG, IgM, IgA, or IgE
synthesis when cultured with
purified B cells, and inhibits Ig
synthesis when coculturedwith
doneH9 (secreting IL-2, IL-4,
and IFN-,y) and B cells . B cells
that expressed alloantigens rec-
ognized byboth clones were cul-
tured with clone H8 (40,000
cells/well), with clone H9
(40,000 cells/well), or with both
clones H8 and H9 . Superna-
tants were taken after 9d ofcul-
ture and examined for IgG,
IgM, IgA, and IgE .
Purified B cells were cultured for 9 d under cognate conditions with clone H9
(secretes IL-2, IL-4, and IFN-y), which was pretreated with cyclosporin A (3
l+g/ml for 16 h) to inhibit lymphokine release . Supernatants from B cell/cloned
T cell cultures were harvested and tested for Ig content by ELISA . IL-2 was
used at 4 U/ml, IL-4 at 500 U/ml, and LMW-BCGF at 1 :20 dilution .
B cells
T cells
cultured with :
Lymphokines IgG IgM IgE
ng/ml
H9untreated None 56,250 49,000 23.00
H9e'a None 903 <195 <0.31
H9 esa IL-2 + IL-4 + BCGF 22,224 42,300 463.00
None None 437 <195 <0.31
None IL-2 + IL-4 + BCGF 161 <195 3.701486 INTERLEUKIN 4 AND B CELL GROWTH FACTOR IN IgE SYNTHESIS
tively induce IgE but not IgG synthesis. TableVII shows that addition ofIL-4with
LMW-BCGF selectively enhanced IgE synthesis (Table VII, lines 7 and 15). The
IgE-enhancingeffect ofLMWBCGF and IL-4 was specific for IgE synthesis since
addition of LMWBCGF with IL-2 or of IL-4 with IL-2 resulted in synthesis of
only small amounts of IgE. Addition of IL-4 alone (Table VII, line 3), even with
IL-4 from two different sources (Genzyme and Amgen) and with doses up to 300
ng/ml (data not shown), had no effect on the induction ofIgE. This again indicated
that while IL-4 was important for IgE synthesis, it was not sufficient. Addition of
IL-5 alone, or of LMW-BCGF alone (Table VII, lines 4 and 5) also had no effect
on IgE or on IgG synthesis.
In contrast, addition ofIL-2 (line 2), or ofIL-2 + LMW-BCGF (line 14), to cul-
tures ofpurified Bcells and cyclosporin A-pretreated clone 119, resulted in the syn-
thesis of IgG, IgM, and IgA, but only minimal amounts of IgE. This confirmed
the importance ofIL-2 in the induction of IgG and IgM, and suggested that IL-2
was also important in thesynthesisofIgA. SinceIgG butnot IgE synthesisoccurred
when IL-2 or IL-2 + LMW-BCGF were added, and since irradiation of the
cyclosporin-treated T cell clone had no effect on these results (data not shown), it
was unlikely that IL-2 was simply acting to improve the survival ofthe T cell clone
or to improve lymphokine secretion from the Tcell clone. Although IL-2 by itself
had little effect on IgE synthesis, the combination of IL-2 with IL-4 and LMW-
Exp.
2
TABLE VII
Induction of Ig Synthesis with Clone H9 Pretreated with Cyclosporin A
Purified B cells were cultured as described in Table VI. IL-2 was used at 4 U/ml,
IL-4 (from Genzyme) at 500 U/ml, IL-5 (from Genetics Institute) at 1 :500, and
LMW-BCGF at 1 :20 dilution.
B cells cultured with: IgG IgM IgA IgE
ng/ml
H9`sa 227 <200 260 <0 .31
H91sa + IL-2 5,791 10,470 4,900 0.53
H9`sa + IL-4 297 <200 915 0.49
H9111 + IL-5 252 <200 238 <0.31
H9111 + BCGF 276 <200 594 <0.31
H91e1 + IL-4 + IL-5 330 <200 212 0.62
H91sa + IL-4 + BCGF 479 <200 697 42 .30
H9111 + IL-2 + IL-4 8,983 11,184 7,219 2 .00
H9111 + IL-2 + IL-4 + BCGF 7,387 10,600 2,633 123 .10
IL-2 + BCGF 373 <200 607 0.35
IL-4 + BCGF 314 <200 590 0.80
IL-2 + IL-4 + BCGF 968 320 771 2.50
H9cca <30 184 <20 <0.31
H9- + IL-2 + BCGF 8,003 16,576 3,631 3.41
H9111 + IL-4 + BCGF 710 1,341 2,094 33.20
H9ua + IL-2 + IL-4 + BCGF 5,291 7,189 3,928 97.00
H9`sa + IL-2 + IL-4 + IL-5 5,752 12,828 2,011 1 .17
IL-2 + BCGF 414 696 801 <0.31
IL-4 + BCGF 127 264 640 2.1
IL-2 + IL-4 + BCGF 960 248 671 2.63
IL-2 + IL-4 + IL-5 815 320 379 0.45DEKRUYFF ET AL.
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BCGF resulted in a significant increase in IgE synthesis. This suggested that IL-2
was important incombination withotherlymphokinesfor theinduction ofIgE syn-
thesis, orthat IL-2 hadbeneficial effectson thesurvivalorfunction ofthe Tcellclones.
IL-5 CannotSubstituteforLMW-BCGFintheInductionofIgESynthesiswith Cyclosporin-
pretreated with TCellClones. Since IL-5 enhances the secretion ofIgG and IgA (but
notofIgE) in mice (8, 37-39), andunder suboptimal conditions enhances secretion
of IgE in man (40), we asked if the addition of recombinant IL-5 enhanced IgE
synthesis usingoursystem withcyclosporinA pretreatedTcell clones. Resultsusing
rIL-5 from Genetics Institute, shown inTableVII (lines 4, 6, and 17), indicate that
rIL-5 alone or in combination with IL-4, orwith IL-2 had little effect on IgE syn-
thesis even in the presence of the T cell clone. Similar results were obtained with
rIL-5 from DNAX (data not shown). In contrast, the combination of IL-2, IL-4,
and LMW-BCGF in the presence of the T cell clone resulted in the synthesis of
>100 ng/ml of IgE. Collectively, these results indicated that neither IL-4 nor IL-5
could substitute for LMW-BCGF, and therefore, the IgE-enhancing effect in the
LMWBCGFpreparationwasunlikelytobedueto acontaminant suchas IL-4orIL-5.
Discussion
There is general agreement that IL-4 is required for the synthesis ofboth human
and murine IgE (2-9, 12-16). Inman, however, the results ofstudyingIgE synthesis
have been less clear cut than in the mouse. Polyclonal B cell activators such as LPS,
Staphylococcus A, Cowan strain (SAC), anti-Ig, PWM, or EBV do not induce IgE
synthesis, even in the presence ofIL-4 (41-43). More recently, several investigators
have shown that when IL-4 or antigen nonspecific human T cell clones producing
IL-4, were added to unfractionated PBMC or to B cell-enriched populations, IgE
synthesis was induced (12-16). The results ofthese experiments indicated that IL-4
was an important lymphokine in the induction ofhuman IgE synthesis, and that
IFN-y had an inhibitory effect on IgE synthesis. However, IgE synthesis in these
systems required thepresenceofsizable numbersofperipheral blood T cells, there-
fore making it difficultto knowwhat signalswere providedbyIL-4 and whatsignals
were providedviathestimulation ofthecontaminatingT cells thatproduced a second
required factor(s). Moreover, although induction ofIgE correlated positively with
the presence ofT cell clones producing IL-4 and negatively with clones producing
IFN-y, some clones that made IL-4 did not induce IgE, and some clones that made
IFN-y were potent inducers of IgE (12, 13, 16). This indicated that lymphokines
or factorsin addition to IL-4 were important in the induction ofIgE synthesis, and
that the mechanisms for the induction ofIgE synthesis were more complex than
suggested by data generated in the mouse with LPS.
In the currentarticle we studied the inductionofIgE synthesis in severelyT cell-
depleted B cell populationswithanumberofwell-characterized antigen-specific helper
CD4' T cell clones, each with a different profile oflymphokine synthesis, to deter-
mine what signals in addition to IL-4 were required for the induction of IgE syn-
thesis. Our system with T cell clones, differs from previous studies(12, 13, 16), that
showed the requirement of IL-4, in that we used purified B cell populations with
antigen-specific clones undercognate T-B cell conditions, which mimic physiologic
T-B cell MHC-restricted interactions (17-19, 22). Although we did not routinely
measure serum IgE levels in our donors to assess their allergic status, and although1488 INTERLEUKIN 4 AND B CELL GROWTH FACTOR IN IgE SYNTHESIS
some of our purified B cell populations contained some large preactivated B cells
that secreted small amounts of IgE spontaneously, the response induced with our
T cell clones in our unfractionated T cell-depleted B cells was 40-100 times that
ofthis spontaneous background. Finally, using cyclosporin A-pretreated clones, we
were able to functionally dissect the signals provided by the direct interaction of
the T cell with the B cell from signals provided by lymphokines.
Our results using these different experimental approaches showed that optimal
induction ofIgE synthesis required exposure ofB cells to a particular complex of
signals, that included signals provided by (a) Th-B cell interaction that primed B
cellsto receive additionalsignalsfromsolublelymphokines, (6) by IL-4, (c) by LMW-
BCGF, and (d) by IL-2. Therefore, the requirements for IgE synthesis appear to
be different from those for IgG or IgM, and this may allow for the selective regula-
tion of IgE synthesis.
Although the precise characteristics of subsets of human CD4+ T cell clones are
not yet clear (16, 23, 44-46), we have generated antigen-specific human CD4+ T
cell clones with different profiles oflymphokine synthesis and confirmed thatclones
that differ in their lymphokine profiles have differing capacities to induce IgE syn-
thesis. Our detailed analysis of each clone indicated that ofthe clones that did not
produce IL-4, none could induce IgE, and one (clone H8) was inhibitory for IgE
synthesis. The inhibitoryeffect ofcloneH8on IgE synthesiswas unlikely tobe solely
due to synthesis ofIFN-y, since clone H8 also inhibited synthesis ofIg ofall other
isotypes. Another IL-4 nonproducing clone (1311) could be made to induce IgE syn-
thesis by the addition of IL-4. On the other hand, using cyclosporin A-pretreated
T cell clones with purified B cells, addition ofIL-4 alone (even in concentrations
up to 300 ng/ml) (Table VII), or of IL-4 with IL-2 or IL-5 (Table VII), did not
result in IgE synthesis. Thus, using severaldifferent clones and several different ap-
proaches, we have confirmed the idea that IL-4 is required for the induction ofIgE
synthesis, but we have clearly demonstrated that IL-4 by itself is not sufficient.
Although clones that did not produce IL-4 could not induce IgE synthesis, some
oftheclones that produced IL-4 could not induce IgE, again indicatingthat factors
in addition to IL-4 were important for the synthesis of IgE. IL-4-secreting clones
may not proliferate to antigen presented by B cells, as has been shown in mouse
(47) and in man (48), but this is unlikely to account for the failure of some IL-4-
secreting clones to induce IgE, since mouse Th2 clones, which do not proliferate
well to antigen presented by B cells, do secrete lymphokines after encountering B
cells and are clearly able to induce Ig secretion (8, 31, 49). Moreover, our observa-
tion that LMWBCGF restored the ability ofthe IL-4 secreting "nonhelper" clone
1312to induce IgE(Fig. 2), andourobservation withcyclosporin-treated Tcell clones
thatadditionofIL-4plus LMW-BCGF resulted specificallyinIgE but not IgG syn-
thesis, indicated that LMWBCGF and IL-4, in combination, are lymphokines of
majorimportance inthe induction ofIgE synthesis. LMWBCGF waslikely tohave
a direct effect onB cells rather than an indirect onevia theTcell clone, since LMW-
BCGF had no effect on proliferation of T cell clones (data not shown), and since
the effect was also seen using irradiated T cell clones. It is possible, however, that
LMWBCGF orIL-2 increasedthe survival orenhanced the secretion ofother lym-
phokines from the cyclosporin A-treated T cell clone.
Now what is LMW-BCGF? LMWBCGF represents the predominant moleculeDEKRUYFF ET AL.
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that has comitogenic effects on activated human B cells and that is released from
normal lectin-activated human T cells (34). It has a molecular weight of 12 x 103,
with a major isoelectric point of6.3-6.6. cDNA for this molecule has been cloned
and sequencedby Sharmaet al. (50). The commercial preparationofLMWBCGF
thatweused contained smallamounts ofcontaminants, but these(IFN-y, CSF, and
lymphotoxin [51]) do not enhance IgE synthesis (13, 16). The IgE-enhancing ac-
tivity in the commercial preparation was unlikely to be due to IL-4 or IL-5 since
two different preparations ofrIL-5 and two different preparations ofrIL-4 in large
quantities were all unable to substitute for LMW-BCGF in our cultures, and since
IL-4 was undetectable by immunoassay in the commercial preparation of LMW-
BCGF (20). However, the possibility that the IgE-enhancing activity in the com-
mercial preparation ofLMWBCGF was due to a contaminant cannot be formally
ruled out until recombinant LMW-BCGF is available.
Nevertheless, LMWBCGF isknowntobe apotent B cellgrowth factor (34), which
can act inconcert with IL-4 to induce proliferationofanti-IgM preactivated B cells
(35, 36). LMWBCGF by itselfdoes not induce B cell differentiation (34), and may
actuallyinhibit IgGsynthesis. Itsrole then inIgEsynthesis may be toinduce prolifer-
ation andexpansionofpartiallyactivated B cells, and tocause Bcells to bereceptive
to differentiation signalsfromIL-4. Since addition ofLMW-BCGF alone, IL-2 alone,
or IL-4 alone to our cultures ofB cells and T cell clones did not result in the syn-
thesis of significant amounts ofIgE, we suggest that under physiologic conditions,
anoptimal IgE response requires the presenceofboth agrowth factor suchas LMW-
BCGF, as well as a differentiation/isotype switching factor such as IL-4 (7, 52). Al-
though IL-2 is a potent B cell growth factor (53, 54) and is important for induction
of IgG and IgM synthesis (Tables IV, V, VII; and references 37, 55-57), LMW-
BCGF and not IL-2 is the preferred B cell growth factor for IgE synthesis, since
addition ofIL-2 + IL-4 to our cultures in the absence ofLMWBCGF did not re-
sult in substantial IgEsynthesis. Although IL-4 itselfcan undersome circumstances
also induce B cell growth (50, 51, 58), in our culture system IL-4 without LMW-
BCGFhadlittleeffect on IgE synthesis. It is possible, however, that in B cellpopula-
tions where the frequency ofIgE-committed B cells is high, IL-4 alone may induce
differentiation resulting in a substantial IgE response.
While our results show the enhancing effect on IgE synthesis ofthe combination
of soluble IL-2, IL-4, and LMWBCGF, we also demonstrated that IgE synthesis
required a signal generated in B cells by the cognate interaction with T cells. Our
normal purified B cell populations did not synthesize appreciable amounts of Ig
in response to soluble lymphokines, except in the presence ofcloned T cells. Fur-
thermore, using cyclosporin A-pretreated T cell clones, we showed that asignal de-
liveredbyaT cell can prime or prepare B cells to receive signals provided by soluble
lymphokines. This is consistent with the hypothesis ofothers (28, 31, 59) that regu-
lation of antibody secretion by T helper cells occurs at two levels: one involves Th
cell/B cellinteraction, and theother involvesT cell-derived lymphokines. Ourresults
extend this hypothesis to the regulation ofIgE synthesis, and show that optimal in-
duction ofan IgE-specificresponserequires (a) a signal involvingTh-B cellinterac-
tion, (b) a specific B cell proliferative signal (LMW-BCGF), and (c) a specific B cell
differentiation signal (IL-4). Although further analysis ofhuman CD4+ Tcells is
required to furtherdefine subsets ofhuman T cells, to determinewhich subsets se-1490 INTERLEUKIN 4 AND B CELL GROWTH FACTOR IN IgE SYNTHESIS
crete LMWBCGF and IL-4, and to determine if other lymphokines or cell types
have important effects on IgE synthesis, our results have refined our understanding
of the specific lymphokine requirements for IgE synthesis and of the role of CD4+
T cell clones in IgE synthesis. Such considerations are essential in developing in-
sights into the regulation of IgE synthesis, and are pertinent in devising strategies
using immunomodulators in vivo to inhibit human IgE immune responses.
Summary
We have analyzed in detail the precise requirements for the induction of human
IgE synthesis using several experimental approaches with purified B cells and well-
characterized alloantigen-specific CD4+ T cell clones expressing different profiles
of lymphokine secretion. Using these clones under cognate conditions in which the
B cells expressed alloantigens recognized by the cloned T cells, we have confirmed
that IL-4 is required for the induction of IgE synthesis, but we have clearly demon-
strated that IL-4 by itself is not sufficient. With several cloned CD4+ T cell lines,
including an IL-4-producing clone that could not induce IgE synthesis, and cloned
T cells pretreated with cyclosporin A to inhibit lymphokine synthesis, we showed
that Th cell-B cell interactions are necessary for IgE synthesis, and that low molec-
ular weight B cell growth factor (LMW-BCGF) and IL-4, in combination, are lym-
phokines of major importancein the induction of IgE synthesis. Together our results
indicate that optimal induction of an IgE-specific response requires the exposure
of B cells to a particular complex of signals that include (a) a signal(s) involving
Th-B cell interaction that primes B cells to receive additional signals from soluble
lymphokines, (b) a specific B cell proliferative signal provided by LMWBCGF, and
(c) a specific B cell differentiation signal provided by IL-4.
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